Dandan Xu Selected Research

Biomarkers (Surrogate Marker)

4/2024	Identification of cellular senescence-associated genes as new biomarkers for predicting the prognosis and immunotherapy response of non-small cell lung cancer and construction of a prognostic model.
3/2024	Vitamin D-binding protein in plasma microglia-derived extracellular vesicles as a potential biomarker for major depressive disorder.
1/2024	Activating transcription factor 3 is a new biomarker correlation with renal clear cell carcinoma progression.
1/2021	Bioinformatics Analysis Reveals the Potential Diagnostic Biomarkers for Abdominal Aortic Aneurysm.
1/2021	Plasma Nesfatin-1: Potential Predictor and Diagnostic Biomarker for Cognitive Dysfunction in T2DM Patient.
1/2020	A time course for markers of protein synthesis and degradation with hindlimb unloading and the accompanying anabolic resistance to refeeding.
1/2015	Serum protein S100A9, SOD3, and MMP9 as new diagnostic biomarkers for pulmonary tuberculosis by iTRAQ-coupled two-dimensional LC-MS/MS.
9/2014	Screening and identification of potential biomarkers and establishment of the diagnostic serum proteomic model for the Traditional Chinese Medicine Syndromes of tuberculosis.
10/2013	The discovery and identification of a candidate proteomic biomarker of active tuberculosis.
1/2013	Screening and identification of six serum microRNAs as novel potential combination biomarkers for pulmonary tuberculosis diagnosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dandan Xu Research Topics

Disease

35	Neoplasms (Cancer) 04/2024 - 12/2017
9	Inflammation (Inflammations) 11/2023 - 08/2016
6	Infections 05/2024 - 04/2012
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 06/2023 - 03/2017
5	Pulmonary Tuberculosis 02/2015 - 01/2012
4	Neoplasm Metastasis (Metastasis) 05/2024 - 08/2021
4	Carcinoma (Carcinomatosis) 01/2024 - 01/2018
4	Body Weight (Weight, Body) 10/2023 - 11/2018
4	Brain Ischemia (Cerebral Ischemia) 11/2021 - 03/2017
4	Esophageal Squamous Cell Carcinoma 01/2021 - 12/2017
3	Carcinogenesis 05/2024 - 01/2019
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2024 - 12/2019
3	Tuberculosis (Tuberculoses) 01/2022 - 10/2013
3	Reperfusion Injury 11/2021 - 01/2021
3	Stroke (Strokes) 01/2021 - 03/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021 - 07/2019
3	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 01/2019 - 04/2017
2	Chronic Obstructive Pulmonary Disease (COPD) 05/2024 - 01/2013
2	Colonic Neoplasms (Colon Cancer) 05/2024 - 12/2023
2	Peripheral Nervous System Diseases (PNS Diseases) 01/2023 - 01/2017
2	Blast Crisis (Blast Phase) 01/2023 - 12/2022
2	Lung Neoplasms (Lung Cancer) 12/2022 - 01/2013
2	Fibrosis (Cirrhosis) 12/2022 - 11/2020
2	Pain (Aches) 03/2022 - 01/2018
2	Ischemic Stroke 01/2022 - 01/2021
2	Rheumatoid Arthritis 01/2022 - 01/2017
2	Arthritis (Polyarthritis) 01/2022 - 01/2017
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 10/2019
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 09/2018
2	Glioma (Gliomas) 11/2021 - 05/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 06/2021 - 09/2018
2	Insulin Resistance 01/2021 - 08/2017
2	COVID-19 01/2021 - 01/2021
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2021 - 01/2018
2	Adenocarcinoma 03/2020 - 11/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2018
2	Colitis 01/2019 - 04/2017
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019 - 08/2014
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2018 - 04/2017
2	Liver Diseases (Liver Disease) 02/2018 - 01/2017
2	Ototoxicity 02/2013 - 11/2012
1	Major Depressive Disorder (Major Depressive Disorders) 03/2024
1	Wounds and Injuries (Trauma) 12/2023
1	Infarction (Infarctions) 11/2023
1	Hypertension (High Blood Pressure) 11/2023
1	Depressive Disorder (Melancholia) 11/2023

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 05/2024 - 01/2012
10	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2013
5	Glucose (Dextrose)FDA LinkGeneric 11/2021 - 08/2017
4	RNA (Ribonucleic Acid)IBA 01/2023 - 04/2012
4	MicroRNAs (MicroRNA)IBA 02/2018 - 04/2012
3	OrexinsIBA 11/2021 - 01/2021
3	Oxygen (Dioxygen)IBA 11/2021 - 01/2021
3	Insulin (Novolin)FDA Link 01/2021 - 08/2017
2	Interleukin-6 (Interleukin 6)IBA 11/2023 - 01/2021
2	CytokinesIBA 11/2023 - 01/2017
2	UbiquitinIBA 01/2023 - 01/2022
2	Phosphotransferases (Kinase)IBA 12/2022 - 03/2019
2	Cyclin D1IBA 06/2022 - 01/2021
2	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 06/2022 - 01/2018
2	AntioxidantsIBA 01/2022 - 01/2017
2	Peptides (Polypeptides)IBA 01/2022 - 01/2021
2	Amino Acids FDA Link 12/2021 - 01/2020
2	Therapeutic UsesIBA 08/2021 - 01/2019
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2021 - 12/2017
2	cepharanthineIBA 01/2021 - 12/2017
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 12/2017
2	Epoxide HydrolasesIBA 07/2019 - 01/2019
2	Caspase 3 (Caspase-3)IBA 07/2019 - 01/2018
2	Inosine Triphosphate (ITP)IBA 01/2019 - 04/2017
2	Photosensitizing Agents (Photosensitizers)IBA 01/2019 - 05/2018
2	CurcuminIBA 01/2018 - 01/2017
2	Neomycin FDA LinkGeneric 02/2013 - 11/2012
2	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 01/2012
1	NitrogenIBA 05/2024
1	Polysaccharides (Glycans)IBA 05/2024
1	OximesIBA 05/2024
1	Tyrosine (L-Tyrosine)FDA Link 05/2024
1	Coal (Coals)IBA 04/2024
1	Vitamin D-Binding ProteinIBA 03/2024
1	Activating Transcription Factor 3IBA 01/2024
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2023
1	Sincalide FDA Link 12/2023
1	CateninsIBA 12/2023
1	Triglycerides (Triacylglycerol)IBA 11/2023
1	Cytidine Triphosphate (CTP)IBA 11/2023
1	IodineIBA 11/2023
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023
1	tocilizumab (atlizumab)FDA Link 11/2023

Therapy/Procedure

20	Therapeutics 12/2023 - 12/2017
7	Drug Therapy (Chemotherapy) 01/2023 - 09/2014
6	Immunotherapy 05/2024 - 06/2021
4	Radiotherapy 11/2018 - 05/2017
3	Transcranial Magnetic Stimulation 01/2023 - 01/2021
3	Aftercare (After-Treatment) 01/2021 - 01/2019
3	Intensity-Modulated Radiotherapy (Radiotherapy, Intensity Modulated) 11/2018 - 05/2017
2	Massage (Zone Therapy) 04/2023 - 01/2022
2	Lymphatic Irradiation 01/2022 - 09/2018
2	Hematopoietic Stem Cell Transplantation 01/2022 - 09/2018
2	Photochemotherapy (Photodynamic Therapy) 01/2019 - 05/2018